The University of Virginia is participating in a clinical research study for adults ages 18 and over, who have extensive stage small cell lung cancer. The purpose of this study is to test if combining the standard of care treatment for small cell lung cancer (carboplatin/cisplatin with etoposide and durvalumab) with monalizumab is safe and if it will keep the cancer from growing or spreading for a longer period of time.
If you choose to be in this study, the exact length of time you are on the study will depend on how you are doing. You can remain in the study as long as you are not having serious side effects, your cancer is not getting worse, or you do not withdraw consent to participate.
Study-related procedures that are being done beyond your standard of care will be provided at no cost to you or your insurance.
Additional information can be found here: https://clinicaltrials.gov/ct2/show/NCT05903092
No Compensation